AFP5h
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE™, XBRYK™)
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCE™ (60mg pre-filled syringe) and XBRYK™ (120mg vial), denosumab biosimilars ...
New cancer report shows Black people face higher mortality rates than white people
Nationally, about 208 Black men per 100,000 died from cancer, as opposed to 179 per 100,000 white men, the study said. About ...